Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting the Transforming Growth Factor-beta Signaling Pathway in the Treatment of Gynecologic Cancer.
Curr Cancer Drug Targets. 2022;23(1):15-24. doi: 10.2174/1568009622666220623115614.
Curr Cancer Drug Targets. 2022.
PMID: 35747971
The Therapeutic Potential of MEK1/2 Inhibitors in the Treatment of Gynecological Cancers: Rational Strategies and Recent Progress.
Ghanaatgar-Kasbi S, Khazaei M, Rastgar-Moghadam A, Ferns GA, Hassanian SM, Avan A.
Ghanaatgar-Kasbi S, et al.
Curr Cancer Drug Targets. 2020;20(6):417-428. doi: 10.2174/1568009620666200424144303.
Curr Cancer Drug Targets. 2020.
PMID: 32329688
Review.
Item in Clipboard
Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma.
Ghanaatgar-Kasbi S, Khorrami S, Avan A, Aledavoud SA, Ferns GA.
Ghanaatgar-Kasbi S, et al.
Curr Pharm Des. 2018;24(39):4619-4625. doi: 10.2174/1381612825666190110145855.
Curr Pharm Des. 2018.
PMID: 30636579
Review.
Item in Clipboard
AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
Ghanaatgar-Kasbi S, Amerizadeh F, Rahmani F, Hassanian SM, Khazaei M, Ferns GA, Avan A.
Ghanaatgar-Kasbi S, et al.
IUBMB Life. 2019 Dec;71(12):1929-1936. doi: 10.1002/iub.2136. Epub 2019 Jul 30.
IUBMB Life. 2019.
PMID: 31359579
Free article.
Item in Clipboard
Cite
Cite